Multiple endocrine neoplasia type 2 screening: Difference between revisions
No edit summary |
|||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
According to the American Society of Clinical Oncology, screening for multiple endocrine neoplasia type 2 by ''RET'' gene testing is recommended for children with increased risk of multiple endocrine neoplasia type 2. | According to the American Society of Clinical Oncology, screening for multiple endocrine neoplasia type 2 by ''RET'' gene testing is recommended for children with increased risk of multiple endocrine neoplasia type 2. | ||
==Screening== | ==Screening== | ||
* Screening for multiple endocrine neoplasia type 2 include the following. | * Screening for multiple endocrine neoplasia type 2 include the following. |
Revision as of 02:19, 29 September 2015
Multiple endocrine neoplasia type 2 Microchapters |
Differentiating Multiple endocrine neoplasia type 2 from other Diseases |
---|
Diagnosis |
Treatment |
Multiple endocrine neoplasia type 2 screening On the Web |
American Roentgen Ray Society Images of Multiple endocrine neoplasia type 2 screening |
Directions to Hospitals Treating Multiple endocrine neoplasia type 2 |
Risk calculators and risk factors for Multiple endocrine neoplasia type 2 screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Overview
According to the American Society of Clinical Oncology, screening for multiple endocrine neoplasia type 2 by RET gene testing is recommended for children with increased risk of multiple endocrine neoplasia type 2.
Screening
- Screening for multiple endocrine neoplasia type 2 include the following.
References
|